Literature DB >> 19483153

Definition, diagnosis and treatment of immune thrombocytopenic purpura.

James N George.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19483153      PMCID： PMC2688564          DOI： 10.3324/haematol.2009.007674

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  17 in total

1.  Morbidity and mortality in adults with idiopathic thrombocytopenic purpura.

Authors:  J E Portielje; R G Westendorp; H C Kluin-Nelemans; A Brand
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

Review 2.  Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications.

Authors:  Kiarash Kojouri; Sara K Vesely; Deirdra R Terrell; James N George
Journal:  Blood       Date:  2004-06-24       Impact factor: 22.113

Review 3.  Management of patients with refractory immune thrombocytopenic purpura.

Authors:  J N George
Journal:  J Thromb Haemost       Date:  2006-08       Impact factor: 5.824

Review 4.  Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura.

Authors:  Donald M Arnold; Francesco Dentali; Mark A Crowther; Ralph M Meyer; Richard J Cook; Christopher Sigouin; Graeme A Fraser; Wendy Lim; John G Kelton
Journal:  Ann Intern Med       Date:  2007-01-02       Impact factor: 25.391

5.  Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.

Authors:  Yunfeng Cheng; Raymond S M Wong; Yannie O Y Soo; Chung Hin Chui; Fung Yi Lau; Natalie P H Chan; Wai Shan Wong; Gregory Cheng
Journal:  N Engl J Med       Date:  2003-08-28       Impact factor: 91.245

Review 6.  Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.

Authors:  J N George; S H Woolf; G E Raskob; J S Wasser; L M Aledort; P J Ballem; V S Blanchette; J B Bussel; D B Cines; J G Kelton; A E Lichtin; R McMillan; J A Okerbloom; D H Regan; I Warrier
Journal:  Blood       Date:  1996-07-01       Impact factor: 22.113

7.  Platelet activation in Helicobacter pylori-associated idiopathic thrombocytopenic purpura: eradication reduces platelet activation but seldom improves platelet counts.

Authors:  Eugene R Ahn; Maike P Tiede; Wenche Jy; Carlos J Bidot; Vincenzo Fontana; Yeon S Ahn
Journal:  Acta Haematol       Date:  2006       Impact factor: 2.195

8.  Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan.

Authors:  Kingo Fujimura; Masataka Kuwana; Yoshiyuki Kurata; Masahiro Imamura; Hiroshi Harada; Hisashi Sakamaki; Masanao Teramura; Kyuhei Koda; Shosaku Nomura; Sayaka Sugihara; Takeshi Shimomura; Tetsuro-Takahiro Fujimoto; Kazuma Oyashiki; Yasuo Ikeda
Journal:  Int J Hematol       Date:  2005-02       Impact factor: 2.490

9.  Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives.

Authors:  Jacqueline A Guidry; James N George; Sara K Vesely; Shelia M Kennison; Deirdra R Terrell
Journal:  Eur J Haematol       Date:  2009-04-04       Impact factor: 2.997

10.  Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura?

Authors:  Marc Michel; Nichola Cooper; Christelle Jean; Christine Frissora; James B Bussel
Journal:  Blood       Date:  2003-08-14       Impact factor: 22.113
View more
  7 in total

1.  Comment to the article by Arai Y, Jo T, Matsui H, Kondo T and Takaori-Kondo A: "Comparison of up-front treatments for newly diagnosed immune thrombocytopenia - a systematic review and network meta-analysis". Haematologica 2018;103(1):163-171. Need to direct immune thrombocytopenia therapy towards shared goals.

Authors:  Lorenzo Cirasino; Stefano Semeraro
Journal:  Haematologica       Date:  2018-06       Impact factor: 9.941

2.  Macrothrombocytopenia associated with a rare GFI1B missense variant confounding the presentation of immune thrombocytopenia.

Authors:  Aaron N Cheng; Erik L Bao; Claudia Fiorini; Vijay G Sankaran
Journal:  Pediatr Blood Cancer       Date:  2019-06-17       Impact factor: 3.167

3.  Is Autoimmune Thrombocytopenia Itself the Primary Disease in the Presence of Second Diseases Data from a Long-Term Observation.

Authors:  Nasra Aboud; Fabian Depré; Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2016-10-18       Impact factor: 3.747

4.  Wet purpura: a sinister sign in thrombocytopenia.

Authors:  Kundan Mishra; Aditya Jandial; Pankaj Malhotra; Neelam Varma
Journal:  BMJ Case Rep       Date:  2017-09-01

5.  A risk score for predicting hospitalization for community-acquired pneumonia in ITP using nationally representative data.

Authors:  Ye-Jun Wu; Ming Hou; Hui-Xin Liu; Jun Peng; Liang-Ming Ma; Lin-Hua Yang; Ru Feng; Hui Liu; Yi Liu; Jia Feng; Hong-Yu Zhang; Ze-Ping Zhou; Wen-Sheng Wang; Xu-Liang Shen; Peng Zhao; Hai-Xia Fu; Qiao-Zhu Zeng; Xing-Lin Wang; Qiu-Sha Huang; Yun He; Qian Jiang; Hao Jiang; Jin Lu; Xiang-Yu Zhao; Xiao-Su Zhao; Ying-Jun Chang; Lan-Ping Xu; Yue-Ying Li; Qian-Fei Wang; Xiao-Hui Zhang
Journal:  Blood Adv       Date:  2020-11-24

Review 6.  Approach to Helicobacter pylori infection in geriatric population.

Authors:  Sevdenur Cizginer; Zehra Ordulu; Abdurrahman Kadayifci
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-08-06

7.  Evaluation of 143 cases of immune thrombocytopenic purpura with regards to clinical course and response to treatment.

Authors:  Murat Albayrak; Ozlem Sahin Balcik; Sahika Zeynep Aki; Ayla Gokmen; Funda Ceran; Osman Yokus; Simten Dagdas; Meltem Ayli; Gulsum Ozet
Journal:  Eurasian J Med       Date:  2010-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.